Novo Nordisk A-S
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $78,488,000 | $96,823,000 | $79,144,000 | $74,976,000 |
Gross Profit | 61,388,000 | 83,225,000 | 63,996,000 | 57,072,000 |
EBITDA | 38,679,000 | 69,207,000 | 39,747,000 | 33,274,000 |
EBIT | 28,375,000 | 65,671,000 | 34,185,000 | 25,517,000 |
Net Income | 20,989,000 | 48,557,000 | 26,891,000 | 20,006,000 |
Net Change In Cash | 78,488,000 | 96,823,000 | 79,144,000 | 74,976,000 |
Free Cash Flow | 42,398,000 | 12,045,000 | -36,218,000 | 30,692,000 |
Cash | 44,482,000 | 21,127,000 | 26,464,000 | 32,084,000 |
Basic Shares | 4,435,800 | 4,448,700 | 4,447,851 | 4,446,800 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $309,064,000 | $290,403,000 | $232,261,000 | $176,954,000 |
Gross Profit | 250,276,000 | 245,881,000 | 196,496,000 | 148,506,000 |
EBITDA | 156,729,000 | 147,938,000 | 114,629,000 | 76,802,000 |
EBIT | 134,747,000 | 128,831,000 | 105,216,000 | 69,440,000 |
Net Income | 102,434,000 | 100,988,000 | 83,683,000 | 55,525,000 |
Net Change In Cash | 309,064,000 | 290,403,000 | 232,261,000 | 176,954,000 |
Free Cash Flow | 28,989,000 | 69,659,000 | 70,012,000 | 64,134,000 |
Cash | 26,464,000 | 15,655,000 | 14,392,000 | 12,653,000 |
Basic Shares | 4,447,851 | 4,463,000 | 4,494,800 | 4,544,600 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.96 |
2026-03-31 | $6.63 |
2025-12-31 | $6.04 |
2025-09-30 | $1.02 |